Risk driven decision for high-dose therapy in multiple myeloma - No

被引：0
|
作者：
Goldschmidt, H. [1 ]
机构：
[1] Univ Klinikum Heidelberg, Med Klin, Innere Med 5, Heidelberg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V800
引用
收藏
页码：242 / 242
页数：1
相关论文
共 50 条
  • [41] High-dose therapy autotransplantation/intensification in multiple myeloma: pretransplant predictors of complete remission
    Gine, E
    Nadal, E
    Blade, J
    Esteve, J
    Aviles, FF
    Martinez, C
    Rovira, M
    Ispizua, AU
    Marin, P
    Nomdedeu, B
    Carreras, E
    Montserrat, E
    BONE MARROW TRANSPLANTATION, 2003, 31 : S84 - S85
  • [42] High-dose therapy and autologous stem cell transplant in older adults with multiple myeloma
    T M Wildes
    J D Finney
    M Fiala
    F Gao
    R Vij
    K Stockerl-Goldstein
    K R Carson
    J Mikhael
    G Colditz
    Bone Marrow Transplantation, 2015, 50 : 1075 - 1082
  • [43] Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma
    G P Kaufman
    M A Gertz
    A Dispenzieri
    M Q Lacy
    F K Buadi
    D Dingli
    S R Hayman
    P Kapoor
    J A Lust
    S Russell
    R S Go
    Y L Hwa
    R A Kyle
    S V Rajkumar
    S K Kumar
    Leukemia, 2016, 30 : 633 - 639
  • [44] Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma
    Kaufman, G. P.
    Gertz, M. A.
    Dispenzieri, A.
    Lacy, M. Q.
    Buadi, F. K.
    Dingli, D.
    Hayman, S. R.
    Kapoor, P.
    Lust, J. A.
    Russell, S.
    Go, R. S.
    Hwa, Y. L.
    Kyle, R. A.
    Rajkumar, S. V.
    Kumar, S. K.
    LEUKEMIA, 2016, 30 (03) : 633 - 639
  • [45] High-dose therapy and autologous stem cell transplant in older adults with multiple myeloma
    Wildes, T. M.
    Finney, J. D.
    Fiala, M.
    Gao, F.
    Vij, R.
    Stockerl-Goldstein, K.
    Carson, K. R.
    Mikhael, J.
    Colditz, G.
    BONE MARROW TRANSPLANTATION, 2015, 50 (08) : 1075 - 1082
  • [46] Impact of low-dose thalidomide as maintenance therapy in advanced multiple myeloma patients following high-dose therapy
    Andreini, A.
    Ruggeri, G.
    Sorio, M.
    Tecchio, C.
    Frattini, F.
    Ledro, S.
    Perbellini, C.
    de Sabata, D.
    Quaresmini, G.
    Benedetti, F.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S149 - S149
  • [47] Impact of low-dose thalidomide as maintenance therapy in advanced multiple myeloma patients following high-dose therapy
    Andreini, A.
    Randon, F.
    Tecchio, C.
    Quaresmini, G.
    Frattini, F.
    Di Bella, R.
    Sorio, M.
    Ledro, S.
    Perbellini, C.
    de Sabata, D.
    Benedetti, F.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S152 - S152
  • [48] Bortezomib with HIG-dose dexamethasone as first line therapy in patients with multiple myeloma candidates to high-dose therapy
    Corso, Alessandro
    Barbarano, Luciana
    Mangiacavalli, Silvia
    Montalbetti, Luigi
    Brasca, Paola
    Zappasodi, Patrizia
    Carella, Angelo
    Spriano, Mauro
    Alessandrino, Emilio Paolo
    Cairoli, Roberto
    Petro, Daniela
    Varettoni, Marzia
    Bernasconi, Paolo
    Lazzarino, Mario
    Morra, Enrica
    BLOOD, 2007, 110 (11) : 1051A - 1052A
  • [49] High dose therapy in multiple myeloma -: Discussion
    Binet, JL
    Euzéby, J
    Caen, J
    Paolaggi, JP
    Godeau, P
    Queneau, P
    Guénot, M
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2003, 187 (02): : 413 - 415
  • [50] High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy
    S Kumar
    M Q Lacy
    A Dispenzieri
    S V Rajkumar
    R Fonseca
    S Geyer
    C Allmer
    T E Witzig
    J A Lust
    P R Greipp
    R A Kyle
    M R Litzow
    M A Gertz
    Bone Marrow Transplantation, 2004, 34 : 161 - 167
12345